HER2 Support Group Forums - View Single Post - Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimen

News · 08-28-2017, 04:20 AM

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

More...

08-28-2017, 04:20 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,957	Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimen Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice. More...